Status:

ACTIVE_NOT_RECRUITING

FITMI - First In Treating Male Infertility

Lead Sponsor:

Martin Blomberg Jensen

Conditions:

Infertility, Male

Eligibility:

MALE

18-60 years

Phase:

PHASE2

Brief Summary

This RCT aims to assess whether treatment with Denosumab can improve semen quality in infertile men selected by serum AMH as a positive predictive biomarker.

Detailed Description

Background and rationale Infertility is a common problem globally and impaired semen quality is responsible for up to 40% of all cases. Despite the high prevalence there are currently only very limite...

Eligibility Criteria

Inclusion

  • Inclusion Criterias:
  • Infertile men ≥ 18 years and \< 60 years of age
  • Sperm concentration ≤ 20 million pr. mL
  • Serum AMH levels ≥38 pmol/L.
  • The participants must have appropriate Danish or English language skills and give written informed consent.
  • Exclusion Criterias:
  • Chronic diseases, defined as diagnosis where signs, symptoms, and treatment imply an expected long duration and lack of a cure, such as diabetes mellitus, metabolism disorders, osteoporosis, colitis, etc.
  • Sperm concentration \<2 million pr. mL
  • Men with current or previous malignancies, or at potential risk of testicular cancer after baseline examination and ultrasound will be excluded.
  • Men with hypocalcemia at baseline, defined as ionized calcium of \< 1,18 mmol/L or albumin corrected calcium \< 2,17 mmol/L or total calcium \< 2.14 mmol/L
  • Serum vitamin D (25OHD) levels \< 25 nmol/L
  • eGFR \< 60 mL/min/1,73 m2
  • Insufficient dental status
  • Vasectomy
  • Semen volume \< 0.9 mL
  • Hypersensitivity to latex, Denosumab, or to any of the excipients (acetic acid, sodium hydroxide, Sorbitol (E420), Polysorbate 20) will be excluded.

Exclusion

    Key Trial Info

    Start Date :

    January 1 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    September 30 2025

    Estimated Enrollment :

    180 Patients enrolled

    Trial Details

    Trial ID

    NCT05212337

    Start Date

    January 1 2022

    End Date

    September 30 2025

    Last Update

    November 15 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Department of Growth and Reproduction, Rigshospitalet

    Copenhagen, Denmark